U.S. market Closed. Opens in 1 day 10 hours 39 minutes

CNTB | Connect Biopharma Holdings Limited Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue988.00K1.03MN/AN/AN/A
Gross Profit-988.00K-1.03MN/AN/AN/A
Operating Expenses62.07M114.69M97.59M29.36M16.44M
Selling, General & Admin13.53M20.37M19.23M7.31M1.41M
Research & Development51.91M95.26M81.34M23.12M15.44M
Other Operating Expenses-4.35M-940.31K-2.98M-1.07M-411.44K
Operating Income-62.07M-117.66M-99.15M-30.30M-15.99M
Other Expenses / Income2.69M-403.66K-103.21M-89.07M-8.41M
Before Tax Income-59.38M-116.12M-204.94M-119.37M-24.46M
Income Tax Expenses120.00K297.52K266.47K934.46K-442.49K
Net Income-59.50M-116.42M-205.21M-120.30M-24.02M
Interest ExpensesN/A21.03K6.91K6.43K7.69K
Basic Shares Outstanding55.07M55.04M52.27M53.94M55.82M
Diluted Shares Outstanding55.07M55.04M52.27M53.94M55.82M
EBITDA-58.37M-111.31M-204.93M-118.21M-24.78M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-59.38M-116.10M-204.93M-119.36M-24.46M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙